Doctor profile · Federal record
Dr. Jayshree Dhali, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Chicago, IL
- NPI 1952350803
- Accepts Medicare
- MIPS 90.4 / 100 · 2023
- 37 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
2740 W Foster Ave, Suite 316
Chicago, IL 606253500
(773) 769-9200
fax (773) 506-6083 - Additional location
-
2740 W Foster Ave Ste 316
Chicago, IL 606253547 - Mailing address
-
2740 W Foster Ave Ste 316
Chicago, IL 606253547
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- April 8, 2021
- Year of graduation
- 1989 — 37 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Illinois #036-097160
- Medicaid
- IL #036097160
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1952350803. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
859
Distinct HCPCS
5
Medicare allowed
$98,196
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 620 | 271 | $134 | |
83036 |
Hemoglobin a1c level | 95 | 69 | $10 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 66 | 38 | $36 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 56 | 56 | $177 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 22 | 18 | $95 |
In context: peer comparison
Among 41 peers in this city , average services per provider: 186. This provider delivers 4.6× the peer median.Open Payments
Industry payments received
All-time total
$2,804
Transactions
115
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Dexcom, Inc. | 9 | $426.66 | |
| Novo Nordisk Inc | 19 | $404.13 | |
| Corcept Therapeutics | 14 | $351.56 | |
| Amgen Inc. | 15 | $340.58 | |
| Lilly USA, LLC | 8 | $205.27 | |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $190.96 | |
| Amneal Pharmaceuticals LLC | 9 | $148.95 | |
| Radius Health, Inc. | 6 | $131.46 | |
| SANOFI-AVENTIS U.S. LLC | 6 | $123.82 | |
| ABBVIE INC. | 4 | $80.32 | |
| Abbott Laboratories | 4 | $71.33 | |
| Ascensia Diabetes Care Us Inc. | 3 | $65.68 | |
| Medtronic, Inc. | 3 | $58.00 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56.07 | |
| Amphastar Pharmaceuticals, Inc. | 2 | $44.17 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,210
Patients
715
Total drug cost
$1,495,864
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 380 | 110 | $7,631 |
| Metformin Hcl | Generic | 328 | 101 | $4,109 |
| Ozempic (Semaglutide) | Brand | 225 | 58 | $428,283 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 179 | 61 | $184,062 |
| Jardiance (Empagliflozin) | Brand | 156 | 52 | $243,234 |
| Novolog Flexpen (Insulin Aspart) | Brand | 151 | 48 | $212,791 |
| Nano 2nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 134 | 58 | $20,848 |
| Glipizide | Generic | 124 | 43 | $2,250 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 98 | 37 | $135,132 |
| Atorvastatin Calcium | Generic | 80 | 29 | $882 |
Hospital affiliations
Frequently asked questions
What is Dr. Jayshree Dhali's medical specialty?
Dr. Jayshree Dhali practices Endocrinology, Diabetes & Metabolism Physician in Chicago, IL.
Where does Dr. Jayshree Dhali practice?
Dr. Jayshree Dhali practices at 2740 W Foster Ave, Chicago, IL 606253500. Office phone: 7737699200.
What is Dr. Jayshree Dhali's NPI?
Dr. Jayshree Dhali's National Provider Identifier (NPI) is 1952350803, issued by NPPES.
Does Dr. Jayshree Dhali accept Medicare assignment?
Yes. Dr. Jayshree Dhali accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jayshree Dhali commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Hemoglobin a1c level (HCPCS 83036); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251). Source: CMS Medicare Physician & Other Practitioners file.